Pressure BioSciences, Inc. (PBIO)
USD 0.01
(-54.89%)
USD 0.01
(-54.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 33.8 Million USD | -2.57% |
| 2022 | 34.69 Million USD | 38.55% |
| 2021 | 25.04 Million USD | 30.29% |
| 2020 | 19.22 Million USD | 38.56% |
| 2019 | 13.87 Million USD | 62.71% |
| 2018 | 8.52 Million USD | -49.2% |
| 2017 | 16.78 Million USD | 67.68% |
| 2016 | 10 Million USD | 2.32% |
| 2015 | 9.78 Million USD | 157.16% |
| 2014 | 3.8 Million USD | 23.86% |
| 2013 | 3.07 Million USD | 6.13% |
| 2012 | 2.89 Million USD | 23.28% |
| 2011 | 2.34 Million USD | 200.49% |
| 2010 | 781.09 Thousand USD | 45.86% |
| 2009 | 535.5 Thousand USD | -26.78% |
| 2008 | 731.36 Thousand USD | -1.58% |
| 2007 | 743.12 Thousand USD | -68.23% |
| 2006 | 2.33 Million USD | -23.16% |
| 2005 | 3.04 Million USD | 135.01% |
| 2004 | 1.29 Million USD | -79.85% |
| 2003 | 6.42 Million USD | -10.93% |
| 2002 | 7.21 Million USD | -9.5% |
| 2001 | 7.97 Million USD | -46.12% |
| 2000 | 14.79 Million USD | 17.45% |
| 1999 | 12.6 Million USD | 26.0% |
| 1998 | 10 Million USD | 81.82% |
| 1997 | 5.5 Million USD | 57.14% |
| 1996 | 3.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 45.11 Million USD | 33.47% |
| 2023 Q4 | 33.8 Million USD | 11.92% |
| 2023 FY | 33.8 Million USD | -2.57% |
| 2023 Q1 | 34.66 Million USD | -0.09% |
| 2023 Q2 | 26.79 Million USD | -22.71% |
| 2023 Q3 | 30.2 Million USD | 12.74% |
| 2022 Q3 | 32.61 Million USD | 8.36% |
| 2022 Q4 | 34.69 Million USD | 6.38% |
| 2022 FY | 34.69 Million USD | 38.55% |
| 2022 Q1 | 27.63 Million USD | 10.37% |
| 2022 Q2 | 30.09 Million USD | 8.9% |
| 2021 Q2 | 24.6 Million USD | 6.94% |
| 2021 Q3 | 23.31 Million USD | -5.27% |
| 2021 Q1 | 23.01 Million USD | 19.73% |
| 2021 FY | 25.04 Million USD | 30.29% |
| 2021 Q4 | 25.04 Million USD | 7.42% |
| 2020 Q3 | 17.49 Million USD | 4.9% |
| 2020 FY | 19.22 Million USD | 38.56% |
| 2020 Q1 | 15.48 Million USD | 11.63% |
| 2020 Q2 | 16.67 Million USD | 7.7% |
| 2020 Q4 | 19.22 Million USD | 9.87% |
| 2019 Q4 | 13.87 Million USD | 15.26% |
| 2019 Q1 | 9.28 Million USD | 8.89% |
| 2019 Q2 | 10.42 Million USD | 12.27% |
| 2019 Q3 | 12.03 Million USD | 15.47% |
| 2019 FY | 13.87 Million USD | 62.71% |
| 2018 FY | 8.52 Million USD | -49.2% |
| 2018 Q4 | 8.52 Million USD | 14.09% |
| 2018 Q3 | 7.47 Million USD | 4.72% |
| 2018 Q1 | 18.74 Million USD | 11.67% |
| 2018 Q2 | 7.13 Million USD | -61.93% |
| 2017 Q2 | 15.23 Million USD | -0.45% |
| 2017 Q1 | 15.3 Million USD | 52.89% |
| 2017 FY | 16.78 Million USD | 67.68% |
| 2017 Q4 | 16.78 Million USD | 15.43% |
| 2017 Q3 | 14.53 Million USD | -4.56% |
| 2016 Q3 | 14.65 Million USD | 2.75% |
| 2016 Q2 | 14.26 Million USD | -9.9% |
| 2016 Q4 | 10 Million USD | -31.7% |
| 2016 Q1 | 15.82 Million USD | 61.81% |
| 2016 FY | 10 Million USD | 2.32% |
| 2015 Q4 | 9.78 Million USD | 45.94% |
| 2015 Q3 | 6.7 Million USD | 17.79% |
| 2015 Q2 | 5.69 Million USD | 20.33% |
| 2015 Q1 | 4.72 Million USD | 24.32% |
| 2015 FY | 9.78 Million USD | 157.16% |
| 2014 Q1 | 2.95 Million USD | -3.91% |
| 2014 Q3 | 3.53 Million USD | 28.42% |
| 2014 FY | 3.8 Million USD | 23.86% |
| 2014 Q2 | 2.75 Million USD | -6.76% |
| 2014 Q4 | 3.8 Million USD | 7.65% |
| 2013 Q4 | 3.07 Million USD | 3.46% |
| 2013 Q2 | 2.65 Million USD | 36.26% |
| 2013 Q1 | 1.94 Million USD | -32.77% |
| 2013 Q3 | 2.96 Million USD | 11.99% |
| 2013 FY | 3.07 Million USD | 6.13% |
| 2012 Q2 | 2.6 Million USD | 10.62% |
| 2012 Q3 | 2.64 Million USD | 1.61% |
| 2012 Q4 | 2.89 Million USD | 9.33% |
| 2012 FY | 2.89 Million USD | 23.28% |
| 2012 Q1 | 2.35 Million USD | 0.32% |
| 2011 Q2 | 1.49 Million USD | 45.47% |
| 2011 FY | 2.34 Million USD | 200.49% |
| 2011 Q4 | 2.34 Million USD | 31.87% |
| 2011 Q3 | 1.77 Million USD | 19.35% |
| 2011 Q1 | 1.02 Million USD | 31.24% |
| 2010 Q1 | 803.72 Thousand USD | 50.09% |
| 2010 FY | 781.09 Thousand USD | 45.86% |
| 2010 Q4 | 781.09 Thousand USD | 1.63% |
| 2010 Q3 | 768.53 Thousand USD | 10.66% |
| 2010 Q2 | 694.48 Thousand USD | -13.59% |
| 2009 Q4 | 535.5 Thousand USD | -23.84% |
| 2009 FY | 535.5 Thousand USD | -26.78% |
| 2009 Q1 | 783.52 Thousand USD | 7.13% |
| 2009 Q2 | 752.8 Thousand USD | -3.92% |
| 2009 Q3 | 703.15 Thousand USD | -6.59% |
| 2008 Q3 | 906.69 Thousand USD | 12.15% |
| 2008 Q2 | 808.46 Thousand USD | -15.28% |
| 2008 Q4 | 731.36 Thousand USD | -19.34% |
| 2008 FY | 731.36 Thousand USD | -1.58% |
| 2008 Q1 | 954.32 Thousand USD | 28.42% |
| 2007 Q4 | 743.12 Thousand USD | -1.81% |
| 2007 FY | 743.12 Thousand USD | -68.23% |
| 2007 Q3 | 756.82 Thousand USD | -26.02% |
| 2007 Q2 | 1.02 Million USD | -61.51% |
| 2007 Q1 | 2.65 Million USD | 13.63% |
| 2006 Q1 | 3.22 Million USD | 5.79% |
| 2006 Q2 | 2.61 Million USD | -18.77% |
| 2006 Q4 | 2.33 Million USD | -10.58% |
| 2006 FY | 2.33 Million USD | -23.16% |
| 2006 Q3 | 2.61 Million USD | -0.01% |
| 2005 Q1 | 2.73 Million USD | 110.91% |
| 2005 FY | 3.04 Million USD | 135.01% |
| 2005 Q4 | 3.04 Million USD | -28.57% |
| 2005 Q3 | 4.26 Million USD | 8.76% |
| 2005 Q2 | 3.91 Million USD | 43.41% |
| 2004 Q2 | 7.18 Million USD | -0.18% |
| 2004 FY | 1.29 Million USD | -79.85% |
| 2004 Q4 | 1.29 Million USD | -75.74% |
| 2004 Q3 | 5.33 Million USD | -25.71% |
| 2004 Q1 | 7.19 Million USD | 12.01% |
| 2003 Q4 | 6.42 Million USD | -1.29% |
| 2003 Q1 | 7.2 Million USD | -0.22% |
| 2003 Q2 | 6.65 Million USD | -7.58% |
| 2003 Q3 | 6.51 Million USD | -2.15% |
| 2003 FY | 6.42 Million USD | -10.93% |
| 2002 Q4 | 7.21 Million USD | -9.4% |
| 2002 Q1 | 7.7 Million USD | -3.42% |
| 2002 FY | 7.21 Million USD | -9.5% |
| 2002 Q2 | 7.25 Million USD | -5.78% |
| 2002 Q3 | 7.96 Million USD | 9.77% |
| 2001 Q2 | 8.42 Million USD | -8.81% |
| 2001 Q1 | 9.24 Million USD | -37.55% |
| 2001 FY | 7.97 Million USD | -46.12% |
| 2001 Q4 | 7.97 Million USD | -4.22% |
| 2001 Q3 | 8.32 Million USD | -1.23% |
| 2000 Q3 | 15.81 Million USD | 13.54% |
| 2000 Q1 | 12.82 Million USD | 1.79% |
| 2000 FY | 14.79 Million USD | 17.45% |
| 2000 Q4 | 14.79 Million USD | -6.41% |
| 2000 Q2 | 13.92 Million USD | 8.58% |
| 1999 Q2 | 10.4 Million USD | 0.0% |
| 1999 FY | 12.6 Million USD | 26.0% |
| 1999 Q1 | 10.4 Million USD | 4.0% |
| 1999 Q3 | 11.3 Million USD | 8.65% |
| 1999 Q4 | 12.6 Million USD | 11.5% |
| 1998 Q2 | 5.2 Million USD | 8.33% |
| 1998 FY | 10 Million USD | 81.82% |
| 1998 Q1 | 4.8 Million USD | -12.73% |
| 1998 Q4 | 10 Million USD | 25.0% |
| 1998 Q3 | 8 Million USD | 53.85% |
| 1997 Q4 | 5.5 Million USD | 22.22% |
| 1997 FY | 5.5 Million USD | 57.14% |
| 1997 Q3 | 4.5 Million USD | 32.35% |
| 1997 Q2 | 3.4 Million USD | -48.48% |
| 1997 Q1 | 6.6 Million USD | 88.57% |
| 1996 FY | 3.5 Million USD | 0.0% |
| 1996 Q4 | 3.5 Million USD | -47.76% |
| 1996 Q3 | 6.7 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | -191.572% |
| BioElectronics Corporation | 16.62 Million USD | -103.356% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -5231.783% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -4888.593% |
| Polarean Imaging plc | 2.58 Million USD | -1209.94% |
| AVITA Medical, Inc. | 19.86 Million USD | -70.163% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -1496.011% |
| Össur hf. | 688.8 Million USD | 95.092% |
| Zecotek Photonics Inc. | 5.86 Million USD | -476.006% |
| QHSLab, Inc. | 2.05 Million USD | -1543.301% |
| Wellstar International, Inc. | 55.99 Million USD | 39.626% |
| Össur hf. | 688.8 Million USD | 95.092% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -110.214% |
| Escalon Medical Corp. | 2.94 Million USD | -1046.526% |
| Aurora Spine Corporation | 6.65 Million USD | -408.053% |
| BrainsWay Ltd. | 15.31 Million USD | -120.736% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -462.207% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 26.262% |
| Vivos Inc. | 245 Thousand USD | -13697.124% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 98.64% |
| Kelyniam Global, Inc. | 1.01 Million USD | -3237.184% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -12164.8% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -1279.843% |
| Nanomix Corporation | 14.81 Million USD | -128.175% |
| Theraclion SA | 13.01 Million EUR | -159.696% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -559.684% |
| Positron Corporation | 2.02 Million USD | -1568.487% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -833.497% |
| Lombard Medical, Inc. | 53.79 Million USD | 37.161% |
| ALR Technologies Inc. | 24.5 Million USD | -37.943% |
| Stratec SE | 271.97 Million USD | 87.571% |
| Vycor Medical, Inc. | 4.31 Million USD | -682.892% |
| Heart Tronics, Inc. | 1.09 Million USD | -2987.673% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -1333.089% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -517.239% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 48.466% |
| VMS Rehab Systems, Inc. | 201.36 USD | -16787496.841% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -517.416% |
| Ingen Technologies, Inc. | 5.7 Million USD | -492.052% |
| Odyssey Group International, Inc. | 6.61 Million USD | -411.266% |
| United American Healthcare Corporation | 119 Thousand USD | -28306.307% |
| ECGI Holdings, Inc. | 11.94 Million USD | -183.103% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -2453.166% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -2237.18% |
| Urologix, Inc. | 12.64 Million USD | -167.348% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -526.448% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -298.511% |
| SS Innovations International, Inc. | 11.18 Million USD | -202.327% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -6334.02% |
| Smith & Nephew plc | 4.76 Billion USD | 99.29% |
| NIOX Group Plc | 9.8 Million USD | -244.86% |
| Fuse Medical, Inc. | 15.11 Million USD | -123.715% |
| Broncus Holding Corporation | 10.43 Million USD | -224.031% |
| Brain Scientific Inc. | 7.42 Million USD | -355.18% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -4156.934% |